NCT00210093View on ClinicalTrials.gov

A Pharmacokinetic Evaluation Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Healthy
Interventions
DRUG

denufosol tetrasodium (INS37217)

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00210093 - A Pharmacokinetic Evaluation Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter